Jonathan Hu (CMO)
Jonathan is responsible for clinical research and development. He has more than 20 years of experience in clinical development in oncology, diabetes, respiratory, infectious, autoimmune, cardiovascular, hematological and ophthalmic diseases.
Joanathan has previously served at Pfizer and Boehringer Ingelheim, and led many global multi-center clinical trials. He has also served as SVP of clinical development at Innovent Biologics, Vice Executive President and CMO of BetaPharma.